Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Immunol Res ; 69(5): 445-456, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34390446

RESUMEN

STAT3 is a cytokine-signaling transcription factor critical for gene regulation. Gain-of-function (GOF) mutations in STAT3 are associated with lymphoproliferation, autoimmune cytopenias, increased susceptibility to infection, early-onset solid-organ autoimmunity, short stature, and eczema. We studied the JAK/STAT signaling pathway gene expression and the cytokine profile in two families carrying STAT3-GOF variants to shed light on the STAT3-GOF-associated variable expressivity, including the identification of disease markers. Considering 92 target genes, KIT and IL2RA were downregulated only in patients with high clinical penetrance, while CXCL8 was markedly downregulated for all of them. Unlike previous studies, SOCS3-a STAT3 inhibitor-was not upregulated in patients. In addition, low levels of IL-2 and a reduced numbers of Tregs cells were strikingly prevalent in patients. This study shows a disruptive role of STAT3-GOF variants in the regulatory axis activities CXCL8/STAT3, KIT/STAT3, IL2/CD25/Treg, which, by slightly different mechanisms, underlie the broad clinical spectrum seen in the studied patients. In addition, we suggest the investigation of CXCL8 as a biomarker for identifying STAT3-GOF mutation.


Asunto(s)
Mutación con Ganancia de Función , Subunidad alfa del Receptor de Interleucina-2/metabolismo , Interleucina-2/metabolismo , Interleucina-8/metabolismo , Factor de Transcripción STAT3/genética , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/metabolismo , Adulto , Preescolar , Hibridación Genómica Comparativa , Citocinas/sangre , Citocinas/metabolismo , Femenino , Regulación de la Expresión Génica , Estudio de Asociación del Genoma Completo , Mutación de Línea Germinal , Heterocigoto , Humanos , Inmunofenotipificación , Recuento de Linfocitos , Masculino , Persona de Mediana Edad , Linaje , Fenotipo , Factor de Transcripción STAT3/metabolismo , Transducción de Señal , Secuenciación del Exoma , Secuenciación Completa del Genoma
2.
PLoS One ; 8(7): e69186, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23869235

RESUMEN

BACKGROUND: The confirmatory diagnosis of Osteogenesis Imperfecta (OI) requires invasive, commonly bone biopsy, time consuming and destructive methods. This paper proposes an alternative method using a combination of two-photon excitation fluorescence (TPEF) and second-harmonic generation (SHG) microscopies from easily obtained human skin biopsies. We show that this method can distinguish subtypes of human OI. METHODOLOGY/PRINCIPAL FINDINGS: Different aspects of collagen microstructure of skin fresh biopsies and standard H&E-stained sections of normal and OI patients (mild and severe forms) were distinguished by TPEF and SHG images. Moreover, important differences between subtypes of OI were identified using different methods of quantification such as collagen density, ratio between collagen and elastic tissue, and gray-level co-occurrence matrix (GLCM) image-pattern analysis. Collagen density was lower in OI dermis, while the SHG/autofluorescence index of the dermis was significantly higher in OI as compared to that of the normal skin. We also showed that the energy value of GLCM texture analysis is useful to discriminate mild from severe OI and from normal skin. CONCLUSIONS/SIGNIFICANCE: This work demonstrated that nonlinear microscopy techniques in combination with image-analysis approaches represent a powerful tool to investigate the collagen organization in skin dermis in patients with OI and has the potential to distinguish the different types of OI. The procedure outlined in this paper requires a skin biopsy, which is almost painless as compared to the bone biopsy commonly used in conventional methods. The data presented here complement existing clinical diagnostic techniques and can be used as a diagnostic procedure to confirm the disease, evaluate its severity and treatment efficacy.


Asunto(s)
Colágeno Tipo I/análisis , Osteogénesis Imperfecta/patología , Piel/patología , Adulto , Biopsia , Niño , Colágeno Tipo I/metabolismo , Humanos , Microscopía de Fluorescencia por Excitación Multifotónica/instrumentación , Microscopía de Fluorescencia por Excitación Multifotónica/métodos , Osteogénesis Imperfecta/metabolismo , Patología/métodos
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda